HIF1A and cancer: By examining and evaluating the distinct prognostic associations across diverse malignancies and by highlighting the role of metabolic, ECM, and EMT pathways, we emphasize the potential of the WWOX/HIF1A ratio as a valuable biomarker for cancer prognosis.